XBI

SPDR S&P Biotech ETF

Up$82.82
+$0.97
(+1.19%)
As of 1:21:44 PM EDT | 5/24/19  |  Market Open

XBI Trading Data

Open

$82.38

Low Price

$82.25

High Price

$83.42

Previous Last Price

$81.85

Bid Size

$82.8 X 200

Ask Size

$82.81 X 200

XBI Portfolio Data

AUM

$4,146,903,600

Shares

50,150

PE Ratio

14.85

Price / Book Ratio

4.91

Expense Ratio

0.35

Net Asset Value

$82.69

Volume

Volume

2,451,805

Avg. Volume (YDT)

5,019,704

Dollar Volume

$184,788,365

Weekly Avg. Volume

4,174,422

Monthly Avg. Volume

5,358,021

Quarterly Avg. Volume

5,260,802

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Array BioPharma Inc. (ARRY)
1.92%
SAGE Therapeutics Inc. (SAGE)
1.91%
Global Blood Therapeutics Inc (GBT)
1.9%
Celgene Corporation (CELG)
1.87%
Exact Sciences Corporation (EXAS)
1.82%
Mirati Therapeutics Inc. (MRTX)
1.8%
Ligand Pharmaceuticals Incorporated (LGND)
1.77%
AbbVie Inc. (ABBV)
1.72%
Gilead Sciences Inc. (GILD)
1.72%
Neurocrine Biosciences Inc. (NBIX)
1.7%

Total XBI Holdings

Total Holdings: 123

Array BioPharma Inc. (ARRY)
1.92%
SAGE Therapeutics Inc. (SAGE)
1.91%
Global Blood Therapeutics Inc (GBT)
1.9%
Celgene Corporation (CELG)
1.87%
Exact Sciences Corporation (EXAS)
1.82%
Mirati Therapeutics Inc. (MRTX)
1.8%
Ligand Pharmaceuticals Incorporated (LGND)
1.77%
AbbVie Inc. (ABBV)
1.72%
Gilead Sciences Inc. (GILD)
1.72%
Neurocrine Biosciences Inc. (NBIX)
1.7%
Alexion Pharmaceuticals Inc. (ALXN)
1.62%
Seattle Genetics Inc. (SGEN)
1.62%
ACADIA Pharmaceuticals Inc. (ACAD)
1.6%
BioMarin Pharmaceutical Inc. (BMRN)
1.6%
Ionis Pharmaceuticals Inc. (IONS)
1.59%
Vertex Pharmaceuticals Incorporated (VRTX)
1.59%
Incyte Corporation (INCY)
1.58%
Amgen Inc. (AMGN)
1.55%
Sarepta Therapeutics Inc. (SRPT)
1.52%
Immunomedics Inc. (IMMU)
1.48%
bluebird bio Inc. (BLUE)
1.47%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.47%
Portola Pharmaceuticals Inc. (PTLA)
1.47%
PTC Therapeutics Inc. (PTCT)
1.47%
Exelixis Inc. (EXEL)
1.46%
Intercept Pharmaceuticals Inc. (ICPT)
1.4%
Amicus Therapeutics Inc. (FOLD)
1.4%
Alnylam Pharmaceuticals Inc (ALNY)
1.33%
Regeneron Pharmaceuticals Inc. (REGN)
1.3%
United Therapeutics Corporation (UTHR)
1.29%
Arena Pharmaceuticals Inc. (ARNA)
1.27%
Ultragenyx Pharmaceutical Inc. (RARE)
1.26%
Biogen Inc. (BIIB)
1.25%
Viking Therapeutics Inc. (VKTX)
1.23%
Myriad Genetics Inc. (MYGN)
1.2%
Repligen Corporation (RGEN)
1.19%
Esperion Therapeutics Inc. (ESPR)
1.16%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
1.15%
Agios Pharmaceuticals Inc. (AGIO)
1.15%
Alkermes Plc (ALKS)
1.08%
FibroGen Inc. (FGEN)
1.06%
Enanta Pharmaceuticals Inc. (ENTA)
1.05%
Acceleron Pharma Inc (XLRN)
1.04%
Clovis Oncology Inc. (CLVS)
1.03%
Madrigal Pharmaceuticals Inc. (MDGL)
1.03%
Editas Medicine Inc. (EDIT)
1.02%
Genomic Health Inc. (GHDX)
1.02%
AnaptysBio Inc. (ANAB)
1.02%
Spark Therapeutics Inc. (ONCE)
1%
Emergent BioSolutions Inc. (EBS)
1%
Blueprint Medicines Corp. (BPMC)
0.97%
Sangamo Therapeutics Inc. (SGMO)
0.92%
CareDx Inc. (CDNA)
0.9%
Vanda Pharmaceuticals Inc. (VNDA)
0.84%
Insmed Incorporated (INSM)
0.82%
Iovance Biotherapeutics Inc (IOVA)
0.81%
REGENXBIO Inc. (RGNX)
0.81%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.77%
Heron Therapeutics Inc (HRTX)
0.74%
Invitae Corp. (NVTA)
0.7%
Fate Therapeutics Inc. (FATE)
0.66%
Allakos Inc. (ALLK)
0.66%
Radius Health Inc (RDUS)
0.65%
OPKO Health Inc. (OPK)
0.63%
Aimmune Therapeutics Inc (AIMT)
0.62%
Audentes Therapeutics Inc. (BOLD)
0.62%
Coherus BioSciences Inc. (CHRS)
0.62%
Natera Inc. (NTRA)
0.59%
Alder Biopharmaceuticals Inc. (ALDR)
0.54%
Acorda Therapeutics Inc. (ACOR)
0.54%
Halozyme Therapeutics Inc. (HALO)
0.54%
Allogene Therapeutics Inc. (ALLO)
0.53%
Cara Therapeutics Inc (CARA)
0.52%
Spectrum Pharmaceuticals Inc. (SPPI)
0.5%
Intrexon Corporation (XON)
0.5%
Atara Biotherapeutics Inc (ATRA)
0.5%
Eagle Pharmaceuticals Inc. (EGRX)
0.46%
ImmunoGen Inc. (IMGN)
0.46%
Vericel Corporation (VCEL)
0.46%
Puma Biotechnology Inc. (PBYI)
0.44%
AMAG Pharmaceuticals Inc. (AMAG)
0.42%
Flexion Therapeutics Inc. (FLXN)
0.4%
G1 Therapeutics Inc. (GTHX)
0.4%
Intellia Therapeutics Inc. (NTLA)
0.39%
Dynavax Technologies Corporation (DVAX)
0.38%
Xencor Inc. (XNCR)
0.37%
Veracyte Inc (VCYT)
0.37%
Stemline Therapeutics Inc. (STML)
0.36%
Momenta Pharmaceuticals Inc. (MNTA)
0.35%
Retrophin Inc. (RTRX)
0.35%
Epizyme Inc. (EPZM)
0.35%
Denali Therapeutics Inc. (DNLI)
0.35%
TG Therapeutics Inc. (TGTX)
0.35%
Ra Pharmaceuticals Inc. (RARX)
0.34%
CytomX Therapeutics Inc. (CTMX)
0.33%
MacroGenics Inc. (MGNX)
0.3%
ZIOPHARM Oncology Inc. (ZIOP)
0.29%
Progenics Pharmaceuticals Inc. (PGNX)
0.29%
Deciphera Pharmaceuticals Inc. (DCPH)
0.26%
Anika Therapeutics Inc. (ANIK)
0.26%
Achillion Pharmaceuticals Inc. (ACHN)
0.24%
Dicerna Pharmaceuticals Inc. (DRNA)
0.24%
Rigel Pharmaceuticals Inc. (RIGL)
0.24%
Akebia Therapeutics Inc. (AKBA)
0.23%
ArQule Inc. (ARQL)
0.21%
Inovio Pharmaceuticals Inc. (INO)
0.21%
Athenex Inc. (ATNX)
0.2%
PDL BioPharma Inc. (PDLI)
0.2%
Apellis Pharmaceuticals Inc. (APLS)
0.17%
Cytokinetics Incorporated (CYTK)
0.17%
Rocket Pharmaceuticals Inc. (RCKT)
0.17%
Prothena Corp. Plc (PRTA)
0.17%
Akcea Therapeutics Inc. (AKCA)
0.17%
Kura Oncology Inc. (KURA)
0.16%
Assembly Biosciences Inc. (ASMB)
0.15%
Five Prime Therapeutics Inc. (FPRX)
0.14%
GlycoMimetics Inc. (GLYC)
0.14%
Rhythm Pharmaceuticals Inc. (RYTM)
0.13%
BioCryst Pharmaceuticals Inc. (BCRX)
0.12%
Cyclerion TherapeuticsInc. (CYCN)
0.1%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.06%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

3.74

Beta

1.83

Leverage

Long

Standard Deviation

7.83

XBI Dividends

Dividend Date

2018-12-21

Latest Dividend

0.012

Annual Dividend

0.14

Annual Dividend Rate

0.14

Annual Dividend Yield

0.17

XBI Performance

YTD Return

15.4%

1 Year Return

-10.71%

3 Year Return

44%

5 Year Return

85.6%

10 Year Return

423%

XBI Related Articles